SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Strategy, Inc. engages in the development of fixed-income instruments that provide investors varying degrees of economic exposure to bitcoin. It executes bitcoin acquisition, capital management, and capital markets strategies. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

Strategys sharp selloff is centered on MSCIs proposed index-screening changes, which traders fear could lead to exclusion and forced selling; the decision is not final. Bearish posts warn of further outflows, while bulls argue the risk is overstated or already priced in, with Bitcoins weakness also cited as pressure.

Ethereum is a global, open-source platform for decentralized applications. In other words, it is a decentralized blockchain platform that enables developers to build and deploy smart contracts and applications without central authority control. Unlike Bitcoin, which primarily functions as digital currency, Ethereum operates as a programmable global computer where developers can create any type of decentralized service.   The platform hosts over $14 billion in DeFi applications with hundreds of thousands of active users across financial protocols, NFT marketplaces, and gaming platforms. Its transition to Proof of Stake in September 2022 reduced energy consumption by over 99%, addressing environmental concerns while strengthening network security.  The network operates through thousands of independent validator nodes that process transactions and execute smart contracts on the Ethereum Virtual Machine. Smart contracts are self-executing programs written in Solidity that automatically carry out agreements when conditions are met, eliminating intermediaries like banks or brokers.   Validators stake ETH as collateral to propose and validate blocks, earning rewards for honest participation while facing penalties for malicious behavior. The EIP-1559 upgrade introduced a dynamic base fee mechanism that burns ETH with each transaction, creating deflationary pressure during high network activity when more ETH is burned than issued to validators.  Vitalik Buterin proposed Ethereum in 2013, but seven co-founders helped build it, including Gavin Wood who created Solidity and the EVM technical specification, and Joseph Lubin who founded ConsenSys. The project launched in July 2015 after raising over $18 million through crowdfunding, quickly becoming the largest blockchain developer community. Major milestones include the 2020 Beacon Chain launch, the 2021 London hard fork implementing fee burning, and the 2022 Merge to Proof of Stake.   Ether (ETH) serves multiple functions: paying transaction fees (gas), staking to secure the network and earn 3-5% annual yields, serving as collateral in DeFi protocols, and purchasing NFTs and digital assets. The asset is increasingly adopted by traditional institutions, with publicly traded companies adding ETH to corporate treasuries to generate staking yields while maintaining blockchain exposure, and in 2024, the SEC approved spot Ethereum ETFs, allowing traditional investors to gain exposure through conventional brokerage accounts.  Ethereum's roadmap focuses on dramatically increasing transaction capacity to over 100,000 per second, reducing confirmation times, and enhancing decentralization while maintaining security against future threats like quantum computing.

Ethereum

Ethereum is drawing attention amid a volatile crypto pullback that traders link to hotter inflation readings, risk-off sentiment and leveraged-position liquidations; ETF outflows and ETHs weaker performance versus bitcoin are also concerns. The community is split between viewing the rebound as a potential bear trap and expecting further downside, with technical support and resistance levels central to the debate.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

A sharp, high-volume selloffattributed by traders to broad biotech weakness and options-expiration trading, with no confirmed company-specific newshas refocused attention on the pending REGAL Phase 3 80th-event announcement and topline data. Bulls interpret the prolonged gap between reported events as a possible sign of extended patient survival, while bears point to the delay and extended quiet period as reasons for concern; neither interpretation is confirmed.

TOSHI

TOSHI is drawing attention as traders watch for a technical rebound, with bullish posts pointing to accumulating volume, chart patterns and a possible short squeeze. Others remain skeptical, citing repeated resistance, continued weakness and broader crypto-market pressure; no confirmed catalyst dominates the discussion.

Grayscale Ethereum Trust (ETH) operates as open-end investment company. Its investment objective is for the shares to reflect the value of ETH held by the trust. The company was founded on December 13, 2017 and is headquartered in Stamford, CT.

Grayscale Ethereum Staking Mini ETF - Common units of fractional undivided beneficial interest

Grayscale Ethereum Mini Trust

Ethereums rebound and breakout momentum, alongside renewed risk-on flows across crypto, are driving attention to the trust. Bullish traders point to ETF inflows, institutional buying and Ethereums role in tokenization, while skeptics question the rallys staying power amid macro volatility and ETHs recent underperformance.

SentinelOne, Inc. engages in the provision of endpoint security software that detects, models, and predicts threat behavior to block attacks on any computing device. Its services include vigilance, support, and training. The company was founded by Tomer Weingarten and Almog Cohen in 2013 and is headquartered in Mountain View, CA.

SentinelOne Inc - Ordinary Shares - Class A

SentinelOne Inc

SentinelOnes convertible-note offering is driving debate over potential dilution and trading pressure versus the benefit of added cash at zero interest. The selloff is also being attributed to broader tech weakness, while bullish traders argue the companys stronger cash position offsets the financing concerns.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

A sharp selloff, alongside weakness across semiconductor and AI-optics stocks, is fueling debate about POETs ability to turn its technology and partnerships into scaled shipments and revenue. Bulls see the cash position and AI-optics opportunity as reasons to buy the dip, while skeptics cite execution concerns, limited commercial proof and dilution risk.

Palo Alto Networks, Inc. engages in the provision of network security solutions to enterprises, service providers, and government entities. It operates through the following geographical segments: the United States, Israel, and Other Countries. The company was founded by Nir Zuk in March 2005 and is headquartered in Santa Clara, CA.

Palo Alto Networks Inc

PANWs steep selloff is being linked in discussion to reports that CISA added an exploited PAN-OS vulnerability to its Known Exploited Vulnerabilities catalog, alongside broader weakness in software and tech stocks. Traders debate whether the flawdescribed in one post as limited in scope with fixes availablejustifies the decline; valuation concerns and dip-buying are also shaping the bearish-versus-rebound conversation.

Uniting the six native Japanese dog breeds. Kendu is the keeper of peace, the preserver of life, and the protector of unity. Join the pack!!

Kendu

Community-led promotion of Kendus expanding real-world brand and initiatives dominates the discussion, including merchandise, products, and events. Traders also celebrate a reported rally and express bullishness, but the conversation is largely promotional rather than focused on a confirmed external catalyst.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Traders are linking reports of possible plague cases across several countries to Arcturuss self-amplifying mRNA vaccine platform, speculating about future infectious-disease vaccine demand; no ARCT program or deal tied to the outbreak is established. Separately, investors are debating the companys OTC deficiency Phase 2 update and LUNAR 2.0 platform, balancing encouraging signals against concerns about development timelines.

statis crypto Watchlist

Bitcoin

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
